These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3082571)

  • 21. Initial experience with oral gold salts in the treatment of rheumatoid arthritis in patients followed up for one year.
    Lignère GC; Giavarini S; Longatti S
    J Int Med Res; 1984; 12(3):193-7. PubMed ID: 6428946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Auranofin (Ridaura). A peroral gold salt].
    Manthorpe R
    Ugeskr Laeger; 1985 Mar; 147(10):888-90. PubMed ID: 3920800
    [No Abstract]   [Full Text] [Related]  

  • 23. Blood and serum concentrations of gold after a single dose of auranofin in children with juvenile rheumatoid arthritis.
    Giannini EH; Person DA; Brewer EJ; Parks DB
    J Rheumatol; 1983 Jun; 10(3):496-8. PubMed ID: 6411921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety].
    Batlle Gualda E
    Med Clin (Barc); 1985 Jun; 85(2):73-9. PubMed ID: 3160899
    [No Abstract]   [Full Text] [Related]  

  • 25. An oral formulation of gold for the treatment of rheumatoid arthritis.
    Meyers OL; Klemp P
    S Afr Med J; 1981 Jun; 59(27):969-71. PubMed ID: 6787721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of gold in rat blood after intravenous administration of auranofin, gold sodium thiomalate and aurothioglucose to rats.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1983 Feb; 10(1):117-20. PubMed ID: 6405031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of auranofin, an oral chrysotherapeutic agent.
    Delafuente JC; Osborn TG
    Clin Pharm; 1984; 3(2):121-7. PubMed ID: 6426843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Auranofin: dose-related risk to benefit.
    Weiss TE
    Am J Med; 1983 Dec; 75(6A):128-32. PubMed ID: 6419594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single dose pharmacokinetics of auranofin in rheumatoid arthritis.
    Blocka K; Furst DE; Landaw E; Dromgoole S; Blomberg A; Paulus HE
    J Rheumatol Suppl; 1982; 8():110-9. PubMed ID: 6813473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral gold therapy in rheumatoid arthritis: auranofin.
    Am J Med; 1983 Dec; 75(6A):1-164. PubMed ID: 6419590
    [No Abstract]   [Full Text] [Related]  

  • 31. Auranofin in rheumatoid arthritis.
    Champion GD; Bieri D; Browne CD; Day RO; Graham GG; Haavisto TM; Sambrook PN; Vallance JB
    J Rheumatol Suppl; 1982; 8():137-45. PubMed ID: 6813475
    [No Abstract]   [Full Text] [Related]  

  • 32. Gold concentrations and toxicity during oral gold treatment with auranofin.
    Sharma RP; Smillie J; Palmer DG
    Pharmacology; 1985; 30(2):115-20. PubMed ID: 3919401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of auranofin on the radiological progression of joint erosion in rheumatoid arthritis.
    Gofton JP; O'Brien WM
    J Rheumatol Suppl; 1982; 8():169-72. PubMed ID: 6813480
    [No Abstract]   [Full Text] [Related]  

  • 34. Oral gold (auranofin) in juvenile rheumatoid arthritis: a 48-week phase II study.
    Kvien TK; Høyeraal HM; Sandstad B; Kåss E
    Clin Rheumatol; 1984 Dec; 3(4):551-2. PubMed ID: 6441669
    [No Abstract]   [Full Text] [Related]  

  • 35. Bronchiolitis in a rheumatoid arthritis patient receiving auranofin.
    O'Duffy JD; Luthra HS; Unni KK; Hyatt RE
    Arthritis Rheum; 1986 Apr; 29(4):556-9. PubMed ID: 3085683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephrotic syndrome after oral gold.
    Atero F; Rodriguez-Franco R; Páramo MJ; Baturone M; Junquera E; Espárrago J; Martinez-Escribano B; Pascual C
    Br J Rheumatol; 1986 Aug; 25(3):315. PubMed ID: 3089353
    [No Abstract]   [Full Text] [Related]  

  • 37. Auranofin in the treatment of rheumatoid arthritis. A two-year study.
    Baldassare AR; Weiss TD; Arthur RE; Osborn TG; Moore TL; Zuckner J
    Mo Med; 1985 Nov; 82(11):711-5. PubMed ID: 3934512
    [No Abstract]   [Full Text] [Related]  

  • 38. Auranofin: more than just oral gold.
    Waller ES
    Clin Pharm; 1984; 3(2):195. PubMed ID: 6426845
    [No Abstract]   [Full Text] [Related]  

  • 39. D-penicillamine as a treatment for toxic reactions to gold therapy.
    Khoury MI
    Arthritis Rheum; 1986 Mar; 29(3):450. PubMed ID: 3083827
    [No Abstract]   [Full Text] [Related]  

  • 40. The efficacy of parenteral gold after auranofin failure in rheumatoid arthritis.
    Wessel J; Davis P
    J Rheumatol; 1983 Aug; 10(4):664. PubMed ID: 6413690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.